✦ LIBER ✦

Erratum to: Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023

✍ Scribed by Bojana Milojkovic Kerklaan, Veronique Diéras…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of lonafarnib (SCH66336) i

✍ Bojana Milojkovic Kerklaan, Veronique Diéras… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 262 KB

0180 Weekly paclitaxel plus carboplatin

✍ X. Chen; C. Chen; J. Wu; J. Wu; J. Lu; Z. Shao; Z. Shen; K. Shen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 64 KB

A phase 2 study of everolimus combined w

✍ Hurvitz, Sara A.; Dalenc, Florence; Campone, Mario; OâRegan, Ruth M.; Tjan-Hei 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 327 KB

Phase I Study of Nonpegylated Liposomal

✍ Maria Theodoulou; Gerald Batist; Susana Campos; Eric Winer; Lauri Welles; Cliffo 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 127 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

A phase II study of bevacizumab in combi

✍ Lin, N. U.; Seah, D. S.; Gelman, R.; Desantis, S.; Mayer, E. L.; Isakoff, S.; Di 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 258 KB